Synergistic GBM treatment was achieved through the combined triple actions of disintegration DHODH and the GPX4 ferroptosis defense mechanism and Fe3O4 NPs‐mediated Fe2+ release (Figure 1c). This evidence concerns the gene GPX4 and glioblastoma.